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Introduction
Modern medicine and medical science have experi-
enced a change in knowledge and dramatic increase in tech-
nology. Nowadays “Hi-Tech” tests are widespread and doc-
tors can hear a statement: “This new test is very reliable, it is
the most sensitive test at the market, you should use it”,
practically every day. The basic idea for using diagnostic
tests aims to easier making the diagnosis of a disease and so
enable appropriate treatment. How to know if a test is use-
ful? Will a test point out to a doctor whether a patient is ill or
not?
Due to the fact that the doctors and medical research
workers are not so common with the statistical methods, the
aim of this paper was to explain the basics of sensitivity,
specificity and predictive values in a very simple way, using
simple logic formulas, and presenting the samples from
medical practice.
Diagnostic test and the gold standard
Diagnostic tests are all the tests that physician can use
in the process of making the diagnosis of a particular disease.
It is a procedure performed to confirm or determine the pres-
ence of a disease in a person suspected of having the disease,
usually following the report on signs and symptoms, or based
on the results of other medical tests 
1.
The most accurate test for determining a disease is a
“gold standard”. Since it represents the best of the existing
tests, we may consider the “gold standard” as a currently pre-
ferred method for diagnosing a specific disease 
2. It is often
invasive or expensive; therefore some other diagnostic test
may be used instead. Hence, a newly designed test has to be
initially validated by comparing its results with a gold stan-
dard due to establish the exact health status of a person.
Some of the known test examples are: uriscreen for urinary
tract infection, blood pressure for hypertension, pap smear
for cervical carcinoma, mammography for breast cancer,
prostate specific antigen (PSA) for prostate cancer, fecal oc-
cult blood for colon cancer, ocular pressure for glaucoma,
colonoscopy to find early cancers and potentially cancerous
polyps, ultrasound for thyroid cancers, nuclear medicine
techniques to examine a lymphoma, measuring blood sugar
for diabetes mellitus, taking a complete blood count for bac-
terial infection 
3. Gold standard may be arbitrary and may
change. When a new test is under consideration for using in
practice it should be good enough to replace the gold stan-
dard for some particular disease, otherwise should be dis-
charged or used as a preliminary test. The doctor’s goal is to
realize which test and testing strategies are best for making
the correct diagnosis.
Validity
Validity is the capability of a test to point out which
people have a disease and which do not. It is the test accu-
racy, or the extent to which a test is able to measure what
should be measured 
4. Validity is estimated by two objective
measures: sensitivity and specificity 
5.
The ideal test should correctly identify all tested people
with or without disease with 100% of accuracy, which is
practically impossible. Traditionally, to help understanding
sensitivity, specificity and predictive values, the best method
for explanation is based on 2 u 2 contingency table. Suppose
a population of 1,000 people, 100 of them have a disease X,
900 do not have the disease according to the gold standard
results (Table 1). Here, the rows represent the screening test
results and the columns the true condition of a person ac-
cording to the gold standard. Screening test is used to iden-
tify 180 people with the disease (a + b).Volumen 71, Broj 11 VOJNOSANITETSKI PREGLED Strana 1063
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Sensitivity
Sensitivity of a clinical test represents test ability to cor-
rectly identify people with illness (a) within all people with
illness (a + c). It is a proportion of people with disease who
positive, expressed in percentages. Sensitivity as a fixed test
characteristic provides a true positive rate 
5, 
6.
negatives False positives True
positives True
y Sensitivit

 
If we apply screening test to our hypothetical popula-
tion and receive that 80 of the 100 people with disease X test
positive, than the sensitivity of this test is 80/100 or 80%
(Table 1). A test with 80% of sensitivity detects 80% of true
ill patients, while 20% (false negative) will not be detected.
Specificity
The specificity of a clinical test represents test ability to
correctly identify people without illness (d) within all people
free from illness (b + d). It is a proportion of people without
disease who test negative. Specificity is also a fixed charac-
teristic of the test and represents true negative rate 
7, 8.
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
 
This hypothetical population (Table 1) demonstrates
that 800 of the 900 people without disease X test negative, so
specificity of this screening test is 800/900 or 89%. Practi-
cally, this test detects 89% of healthy people but 11% will be
assumed as false positive.
For a test to be accurate, both sensitivity and specificity
should be high. When measuring sensitivity, we only calculate
those people with disease. High sensitive test detects a high
percentage of positive cases while missing few. Also, a nega-
tive result would suggest the absence of disease according to
test with high sensitivity. On the contrary, specificity high-
lights negative test results. A highly specific test is good for
detection of a disease if a person tests positive, likewise it does
not falsely diagnose disease when none is present.
It is worthy to mention that specificity and sensitivity of
a quantitative test depend on a cut-off value. This is the value
which determines the limit between positive and negative
test results. In a situation when the cut-off is reduced, most
people with the disease will be correctly identified, but at the
same time the number of false positives will be increased.
Raising the cut-off value will show more false negatives, but
will reduce the number of false positives 
9, 10. Practically,
sensitivity and specificity are inversely proportional, as one
increases the other decreases and vice versa.
The lack of adequate education about interpreting test
results (especially relevant to tests that may have minor and
insignificant findings) may lead to misdiagnosing 
11. It is
known that in two cases if test result doesn't correspond to
the real situation an error has occurred. Therefore it is essen-
tial to pay attention to false positive and false negative test
results. These errors are closely associated with the terms of
type I and type II errors in hypothesis testing. In hypothesis
testing "null hypothesis" matches to the natural state (in our
situation people who are free from disease). As opposed to
the null hypothesis there is an “alternative hypothesis” which
corresponds to the ill people. Type I error, also known as “Į”
error appears when we reject null hypothesis which is actu-
ally correct 
12, 13. Type I error corresponds to the false posi-
tive results. Type II error or “ȕ” error appears when accept-
ing null hypothesis, when actually it is not really true 
12, 13.
This error corresponds to false negative test results. It de-
pends on a situation in which a false result is more undesir-
able. Minimizing false positives and false negatives at the
same time maximizes sensitivity and specificity. Generally,
it is not benign to tell someone after testing that he has a se-
rious disease (false positive) when he does not really have
the same (HIV for example). Moreover, it is inexcusable to
overlook a disease when it really exists (false negative).
Sensitivity and specificity do not depend on the disease
prevalence 
14. They are conditional on the patient either
having or not having a disease and represent the power of a
diagnostic test to discriminate between those with and with-
out disease. When a patient has a positive test result, does it
actually mean that he/she has disease or not? Sensitivity and
specificity cannot answer such a question, thus it is worthy to
know predictive values.
Predictive values
The real questions to be answered are the following:
“What is the probability that a person with a positive test re-
sults will have the disease? Also if a person has a negative
test, what is the likelihood that he is healthy?” These ques-
tions refer to what's called the “predictive values”. Therefore,
the mission of the clinician is to determine the likelihood of a
disease present given a positive test (positive predictive
value – PPV), or the likelihood of a disease absent given a
negative test (negative predictive value – NPV).
Positive predictive value
The positive predictive value or precision rate is de-
fined as a proportion of people with a positive test result (a)
who are actually ill (a + b) 
5, 8. It is calculated by the for-
mula:
Table 1
The table 2 u 2 ( for diagnostic test results)
Disease X
Screening test results present (n) absent (n) Total (n)
Positive 80  (a) 100  (b) 180 (a + b)
Negative 20  (c)  800  (d)  820 (c + d)
Total 100 (a + c) 900 (b + d) 1000 (a + b + c + d)
a – true positive (sick people correctly diagnosed as sick);b – false positive (healthy people wrongly diagnosed as sick); c – false
negative (sick people wrongly diagnosed as healthy); d – true negative (healthy people correctly diagnosed as healthy).Strana 1064 VOJNOSANITETSKI PREGLED Volumen 71, Broj 11
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In our population from 180 (a + b) people who test
positive, 80 (a) of them actually have a disease X. PPV in
this case is 80/180 or 44%. This practically means that a per-
son who tests positive has a 44% likelihood of having a dis-
ease X. Less false positives (higher specificity) signifies a
higher PPV in the observed population.
Negative predictive value
The negative predictive value is defined as a proportion
of people with a negative test result (d) who actually do not
have disease (b + c) 
5, 8. The formula for this measure is:
negatives False negatives True
negatives True
value predictive Negative

 
We can see from our example (Table 1) that out of 820
people disease free, 800 people test negative. That basically
means, a person who tests negative has 800/820 = 0.97 or
97% likelihood of not having a disease. NPP of enormous
99% indicates that a negative screening test actually dis-
misses disease. On the other hand, a very low PPV (only
44%) indicates that every second ill patient is diagnosed
wrongly according to this test. A highly sensitive test (small
number of false negatives) will have a higher NPV in the ob-
served population.
In clinical practice, the value of a test result for an indi-
vidual patient depends on the prevalence of tested population
(the proportion of the population that has the disease at a given
time) 
15, 16. We should expect that for any given population, as
the prevalence of a disease increases, the test PPV will also in-
crease and vice versa, as disease prevalence in the population
being tested decreases, the PPV of that test will also decrease,
while the NPV will increase. To help you understand these
relationships we will illustrate this through the following ex-
ample. Imagine that we now apply the same screening test we
used before (Table 1) to another population where the disease
prevalence is 50%, respectively 500 sick patients out of 1,000
examined (Table 2). Since this is the same test, sensitivity and
specificity remain the same 90% and 80%, respectively. Ac-
cording to this new scenario, PPV is 450/550, or 82%, whereas
the NPV is 400/450, or 89%. In the case when we repeat the
same test to some other population with different disease
prevalence, we will notice that the PPV increases with the in-
creasing disease prevalence while the NPV decreases in the
same situation (Table 3). Though the sensitivity and specificity
remain the same, the PPV has changed remarkably.
The utility of predictive values is limited because the
statistics is determined by sensitivity and specificity of a test,
as well as with the prevalence of disease which can vary 
17.
In general, specificity has more impact on a positive predic-
tive value in the case of low disease prevalence 
18. Constancy
of sensitivity and specificity are an important feature of a test
when using in similar patients and similar settings. Predictive
values although associated with sensitivity and specificity
will change with the prevalence of target disease (Figure 1).
illustrates the effect of the disease prevalence on the PPV
and the NPV. Decreasing the disease prevalence increases
the number of false-positive test results, while increasing the
disease prevalence decreases the number of false-negative
test results.
Table 2
Calculation of predictive values at 50% disease prevalence
Test Disease present (n) Disease absent (n) Total (n)
Positive 450 100 550
Negative 50 400 450
Total 500 500 1000
Prevalence = 500/1000 = 0.5; sensitivity = 450/ 500 = 0.9; specificity = 400/500 = 0.8; PPV = 450/550  = 0.82;
NPV = 400/450  = 0.89; PPV – positive predictive value; NPV – negative predictive value.
Table 3
Relationship between disease prevalence and predictive values
 for a test of 90% sensitivity and 80% specificity
Prevalence (%) Positive predictive value (%) Negative predictive value (%)
5 0.19 0.99
10 0.44 0.97
50 0.82 0.89
70 0.90 0.77
90 0.96 0.47
Fig. 1 – Disease prevalence and predictive valuesVolumen 71, Broj 11 VOJNOSANITETSKI PREGLED Strana 1065
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It is vital to note while comparing two populations that
predictive values are only significant if the disease preva-
lence is the same in both populations. They are used along
with the specificity and sensitivity when the prevalence in
the target population is known. In the case of unknown
prevalence, the sensitivity and specificity are the primary
measurement used to evaluate the accuracy of a test 
19.
Conclusion
To enable interpretation of diagnostic test accuracy it is
necessary to understand the concepts of sensitivity, specific-
ity and predictive values. These calculations require a design
of the two-by-two table. Sensitivity and specificity of a test
have limited clinical usefulness of the disease likelihood in
an individual patient. Although sensitivity and specificity are
not under the influence of the disease prevalence they can be
affected by the differences in disease characteristics. In eve-
ryday clinical practice knowing the predictive values is more
significant for measuring diagnostic accuracy. So, next time
you hear about a new reliable test, ask yourselves what gold
standard is performed, what is the disease prevalence, and
most important of all, what are the sensitivity, specificity,
positive and negative predictive values? If the answers are
satisfactory, you can recommend this test for use.
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